Genotype-phenotype correlation in von Hippel-Lindau disease with retinal angiomatosis

Archives of Ophthalmology

Volumn 125, Issue 2, 2007, Pages 239-245

  Wong, Wai T ^a   Agrón, Elvira ^a   Coleman, Hanna R ^a   Reed, George F ^a   Csaky, Karl ^b   Peterson, James ^a   Glenn, Gladys ^a   Linehan, W Marston ^a   Albert, Paul ^a   Chew, Emily Y ^a,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL EYE INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID;

AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FOLLOW UP; GENE DELETION; GENE MUTATION; GENE STRUCTURE; GENETIC CORRELATION; GENOTYPE PHENOTYPE CORRELATION; GERM LINE; HEMANGIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR GENETICS; MUTATIONAL ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETINA ANGIOMATOSIS; RETINA CAPILLARY; RETINA DISEASE; SAMPLE SIZE; STATISTICAL ANALYSIS; VISUAL ACUITY; VON HIPPEL LINDAU DISEASE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CROSS-SECTIONAL STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; GENOTYPE; GERM-LINE MUTATION; HEMANGIOMA, CAPILLARY; HIPPEL-LINDAU DISEASE; HUMANS; MALE; MIDDLE AGED; MOLECULAR BIOLOGY; PHENOTYPE; PREVALENCE; RETINAL NEOPLASMS; RETINAL VESSELS; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 33846990552     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.125.2.239     Document Type: Article

References (24)

1. Lonser RR, Glenn GM, Walther M, et al. von Hippel-Lindau disease. Lancet. 2003;361:2059-2067.
2. Singh AD, Shields CL, Shields JA. von Hippel-Lindau disease. Surv Ophthalmol. 2001;46:117-142.
3. Vail D. Angiomatosis retinae, eleven years after diathermy coagulation. Am J Ophthalmol. 1958;46:525-534.
4. Annesley WH Jr, Leonard BC, Shields JA, Tasman WS. Fifteen year review of treated cases of retinal angiomatosis. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1977;83(pt 1):OP446-OP453.
5. Blodi CF, Russell SR, Pulido JS, Folk JC. Direct and feeder vessel photocoagulation of retinal angiomas with dye yellow laser. Ophthalmology. 1990;97:791-795.
6. Latif F, Tory K, Gnarra J, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 1993;260:1317-1320.
7. Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971;68:820-823.
8. Maher ER, Iselius L, Yates JR, et al. von Hippel-Lindau disease: a genetic study. J Med Genet. 1991;28:443-447.
9. Stolle C, Glenn G, Zbar B, et al. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Hum Mutat. 1998;12:417-423.
10. Follmann D, Proschan M, Leifer E. Multiple outputation: inference for complex clustered data by averaging analyses from independent data. Biometrics. 2003;59:420-429.
11. Barry RE, Krek W. The von Hippel-Lindau tumour suppressor: a multi-faceted inhibitor of tumourigenesis. Trends Mol Med. 2004;10:466-472.
12. Zbar B, Kishida T, Chen F, et al. Germline mutations in the von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan. Hum Mutat. 1996;8:348-357.
13. Crossey PA, Richards FM, Foster K, et al. Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype. Hum Mol Genet. 1994;3:1303-1308.
14. Chen F, Kishida T, Yao M, et al. Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype. Hum Mutat. 1995;5:66-75.
15. Webster AR, Maher ER, Moore AT. Clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germline mutation. Arch Ophthalmol. 1999;117:371-378.
16. Dollfus H, Massin P, Taupin P, et al. Retinal hemangioblastoma in von Hippel-Lindau disease: a clinical and molecular study. Invest Ophthalmol Vis Sci. 2002;43:3067-3074.
17. Glenn GM, Choyke PL, Zbar B, Linehan WM. von Hippel-Lindau disease: clinical review and molecular genetics. Probl Urol. 1990;4:312-330.
18. McCabe CM, Flynn HW Jr, Shields CL, et al. Juxtapapillary capillary hemangiomas: clinical features and visual acuity outcomes. Ophthalmology. 2000;107:2240-2248.
19. Lamiell JM, Salazar FG, Hsia YE. von Hippel-Lindau disease affecting 43 members of a single kindred. Medicine (Baltimore). 1989;68:1-29.
20. Maher ER, Yates JR, Harries R. Clinical features and natural history of von Hippel-Lindau disease. Q J Med. 1990;77:1151-1163.
21. Chew EY. Ocular manifestations of von Hippel-Lindau disease: clinical and genetic investigations. Am Ophthalmol Soc. 2005;103:495-511.
22. Friedrich CA. Genotype-phenotype correlation in von Hippel-Lindau syndrome. Hum Mol Genet. 2001;10:763-767.
23. Choyke PL, Glenn GM, Walther MM, Patronas NJ, Linehan WM, von Zbar B. Hippel-Lindau disease: genetic, clinical, and imaging features. Radiology. 1995;194:629-642.
24. Moore AT, Maher ER, Rosen P, Gregor Z, Bird AC. Ophthalmological screening for von Hippel-Lindau disease. Eye. 1991;5:723-728.